Search This Blog

Thursday, August 13, 2026

BioStem liquidity, looming milestone payment remain concerns with raised 2026 revenue guidance

 

BioStem Q2 2026 EPS -$0.52 misses, revenue $7.9M beats estimates as company raises 2026 revenue guidance on hospital growth



Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)